JavaScript is disabled in your browser. Please enable JavaScript to view this website.
AB7754

Anti-Cytokeratin 19 antibody [A53-B/A2] - Cytoskeleton Marker

5

(8 Reviews)

|

(66 Publications)

Anti-Cytokeratin 19 antibody [A53-B/A2] - Cytoskeleton Marker (ab7754) is a mouse monoclonal antibody detecting Cytokeratin 19 in Western Blot, Flow Cytometry (Intra), IHC-P, ICC/IF. Suitable for Human.

- KO validated for confirmed specificity
- Over 50 publications
- Trusted since 2001

View Alternative Names

Cytokeratin-19, Keratin-19, CK-19, K19, KRT19, ck19, ck 19

9 Images
Immunohistochemistry (Formalin/PFA-fixed paraffin-embedded sections) - Anti-Cytokeratin 19 antibody [A53-B/A2] - Cytoskeleton Marker (AB7754)
  • IHC-P

AbReview19313****

Immunohistochemistry (Formalin/PFA-fixed paraffin-embedded sections) - Anti-Cytokeratin 19 antibody [A53-B/A2] - Cytoskeleton Marker (AB7754)

ab7754 staining Cytokeratin 19 in Human liver tissue sections by Immunohistochemistry (IHC-P - formaldehyde-fixed, paraffin-embedded sections). Tissue was fixed with formaldehyde and blocked with 5% milk for 30 minutes at 37°C; antigen retrieval was by heat mediation in citrate buffer. Samples were incubated with primary antibody (1/1000 in antibody diluent) for 1 hour at 37°C. An undiluted HRP-conjugated goat anti-rabbit IgG polyclonal was used as the secondary antibody.

This image is courtesy of an anonymous Abreview

Immunocytochemistry/ Immunofluorescence - Anti-Cytokeratin 19 antibody [A53-B/A2] - Cytoskeleton Marker (AB7754)
  • ICC/IF

PubMed

Immunocytochemistry/ Immunofluorescence - Anti-Cytokeratin 19 antibody [A53-B/A2] - Cytoskeleton Marker (AB7754)

Immunofluorescence analysis of 1 month hepato-differentiated Human dental pulp stem cells, staining Cytokeratin 19 with ab7754 at 1/60 dilution. A FITC-conjugated anti-mouse IgG was used as the secondary antibody.

Image from Ferro F et al., PLoS One. 2012;7(7):e41774. Epub 2012 Jul 23. Fig 3.; doi:10.1371/journal.pone.0041774; July 23, 2012, PLoS ONE 7(7): e41774.

Immunohistochemistry (Formalin/PFA-fixed paraffin-embedded sections) - Anti-Cytokeratin 19 antibody [A53-B/A2] - Cytoskeleton Marker (AB7754)
  • IHC-P

Unknown

Immunohistochemistry (Formalin/PFA-fixed paraffin-embedded sections) - Anti-Cytokeratin 19 antibody [A53-B/A2] - Cytoskeleton Marker (AB7754)

ab7754 staining Cytokeratin 19 in human skin.
Left panel : with primary antibody at 2 ug/ml. Right panel : isotype control.
Sections were stained using an automated system (DAKO Autostainer Plus), at room temperature : sections were rehydrated and antigen retrieved with the Dako 3 in 1 AR buffers citrate pH6.1. Slides were peroxidase blocked in 3% H2O2 in methanol for 10 mins. They were then blocked with Dako Protein block for 10 minutes (containing casein 0.25% in PBS) then incubated with primary antibody for 20 min and detected with Dako envision flex amplification kit for 30 minutes. Colorimetric detection was completed with Diaminobenzidine for 5 minutes. Slides were counterstained with Haematoxylin and coverslipped under DePeX. Please note that for manual staining we recommend to optimize the primary antibody concentration and incubation time (overnight incubation), and amplification may be required.

Immunohistochemistry (Formalin/PFA-fixed paraffin-embedded sections) - Anti-Cytokeratin 19 antibody [A53-B/A2] - Cytoskeleton Marker (AB7754)
  • IHC-P

Supplier Data

Immunohistochemistry (Formalin/PFA-fixed paraffin-embedded sections) - Anti-Cytokeratin 19 antibody [A53-B/A2] - Cytoskeleton Marker (AB7754)

Immunohistochemical analysis of paraffin-embedded human liver tissue stained for Cytokeratin 19 using ab7754 at a 1/100 dilution followed by a GAM IgG-Alexa Fluor®488 diluted at 1/200 (green). Cell nuclei stained with PI (1 μg/ml; orange).

Immunocytochemistry/ Immunofluorescence - Anti-Cytokeratin 19 antibody [A53-B/A2] - Cytoskeleton Marker (AB7754)
  • ICC/IF

Unknown

Immunocytochemistry/ Immunofluorescence - Anti-Cytokeratin 19 antibody [A53-B/A2] - Cytoskeleton Marker (AB7754)

ICC/IF image of ab7754 stained HepG2 cells. The cells were 100% methanol fixed (5 min) and then incubated in 1%BSA / 10% normal goat serum / 0.3M glycine in 0.1% PBS-Tween for 1h to permeabilise the cells and block non-specific protein-protein interactions. The cells were then incubated with the antibody ab7754 at 5μg/ml overnight at +4°C. The secondary antibody (green) was DyLight® 488 goat anti- mouse (ab96879) IgG (H+L) used at a 1/1000 dilution for 1h. Alexa Fluor® 594 WGA was used to label plasma membranes (red) at a 1/200 dilution for 1h. DAPI was used to stain the cell nuclei (blue) at a concentration of 1.43μM.

Immunocytochemistry - Anti-Cytokeratin 19 antibody [A53-B/A2] - Cytoskeleton Marker (AB7754)
  • ICC

Lab

Immunocytochemistry - Anti-Cytokeratin 19 antibody [A53-B/A2] - Cytoskeleton Marker (AB7754)

ab7754 staining Cytokeratin 19 in wild-type MCF7 cells (top panel) and KRT19 knockout MCF7 cells (bottom panel). The cells were fixed with 100% methanol (5 min), permeabilized with 0.1% Triton X-100 for 5 minutes and then blocked with 1% BSA/10% normal goat serum/0.3M glycine in 0.1% PBS-Tween for 1h. The cells were then incubated with ab7754 at 1/500 dilution and ab6046 (Rabbit polyclonal to beta Tubulin) at 1/1000 dilution overnight at +4°C, followed by a further incubation at room temperature for 1h with a goat secondary antibody to mouse IgG (Alexa Fluor® 488) (ab150117) at 2 μg/ml (shown in green) and a goat secondary antibody to rabbit IgG (Alexa Fluor® 594) (ab150080) at 2 μg/ml (shown in red). Nuclear DNA was labelled in blue with DAPI.
Image was taken with a confocal microscope (Leica-Microsystems, TCS SP8).

Flow Cytometry (Intracellular) - Anti-Cytokeratin 19 antibody [A53-B/A2] - Cytoskeleton Marker (AB7754)
  • Flow Cyt (Intra)

Unknown

Flow Cytometry (Intracellular) - Anti-Cytokeratin 19 antibody [A53-B/A2] - Cytoskeleton Marker (AB7754)

Overlay histogram showing MCF7 cells stained with ab7754 (red line). The cells were fixed with 80% methanol (5 min) and then permeabilized with 0.1% PBS-Tween for 20 min. The cells were then incubated in 1x PBS / 10% normal goat serum / 0.3M glycine to block non-specific protein-protein interactions followed by the antibody (ab7754, 0.5μg/1x106 cells) for 30 min at 22°C. The secondary antibody used was DyLight® 488 goat anti-mouse IgG (H+L) (ab96879) at 1/500 dilution for 30 min at 22°C. Isotype control antibody (black line) was mouse IgG2a [ICIGG2A] (ab91361, 1μg/1x106 cells) used under the same conditions. Acquisition of >5,000 events was performed.

Flow Cytometry (Intracellular) - Anti-Cytokeratin 19 antibody [A53-B/A2] - Cytoskeleton Marker (AB7754)
  • Flow Cyt (Intra)

Supplier Data

Flow Cytometry (Intracellular) - Anti-Cytokeratin 19 antibody [A53-B/A2] - Cytoskeleton Marker (AB7754)

Separation of MCF-7 cells (red-filled) from human leukocytes (black-dashed) in flow cytometry analysis (intracellular staining) of peripheral whole blood spiked with MCF-7 cells stained using ab7754 (concentration in sample 3 μg/ml, GAM APC).

Western blot - Anti-Cytokeratin 19 antibody [A53-B/A2] - Cytoskeleton Marker (AB7754)
  • WB

Supplier Data

Western blot - Anti-Cytokeratin 19 antibody [A53-B/A2] - Cytoskeleton Marker (AB7754)

Western blotting analysis of human cytokeratin 19 using ab7754 at 2 μg/ml on lysates of HT-29 (Human colorectal adenocarcinoma cell line) cell line and Jurkat (Human T cell leukemia cell line from peripheral blood) cell line (cytokeratin non-expressing cell line; negative control) under non-reducing and reducing conditions.

IRDye800-conjugated anti-mouse IgG1 secondary antibody.

A specific band was detected for cytokeratin 19 at approximately 40 kDa.

All lanes:

Western blot - Anti-Cytokeratin 19 antibody [A53-B/A2] - Cytoskeleton Marker (ab7754)

Predicted band size: 44 kDa

false

  • 519 FITC

    FITC Anti-Cytokeratin 19 antibody [A53-B/A2]

Key facts

Host species

Mouse

Clonality

Monoclonal

Clone number

A53-B/A2

Isotype

IgG2a

Carrier free

No

Reacts with

Human

Applications

IHC-P, ICC/IF, WB, Flow Cyt (Intra)

applications

Immunogen

Cell preparation containing KRT19 protein. The exact immunogen used to generate this antibody is proprietary information.

P08727

Epitope

Rod domain of cytokeratin peptide 19.

Specificity

Rod domain of cytokeratin peptide 19 (40 kDa) in human tissue.

Reactivity data

{ "title": "Reactivity Data", "filters": { "stats": ["", "Species", "Dilution Info", "Notes"], "tabs": { "all-applications": {"fullname" : "All Applications", "shortname": "All Applications"}, "WB" : {"fullname" : "Western blot", "shortname":"WB"}, "ICCIF" : {"fullname" : "Immunocytochemistry/ Immunofluorescence", "shortname":"ICC/IF"}, "FlowCytIntra" : {"fullname" : "Flow Cytometry (Intracellular)", "shortname":"Flow Cyt (Intra)"}, "IHCP" : {"fullname" : "Immunohistochemistry (Formalin/PFA-fixed paraffin-embedded sections)", "shortname":"IHC-P"} }, "product-promise": { "all": "all", "testedAndGuaranteed": "tested", "guaranteed": "expected", "predicted": "predicted", "notRecommended": "not-recommended" } }, "values": { "Human": { "WB-species-checked": "testedAndGuaranteed", "WB-species-dilution-info": "1-2 µg/mL", "WB-species-notes": "<p></p>", "ICCIF-species-checked": "testedAndGuaranteed", "ICCIF-species-dilution-info": "", "ICCIF-species-notes": "<p>Signal can be observed in cells fixed with either methanol or paraformaldehyde.</p>", "FlowCytIntra-species-checked": "testedAndGuaranteed", "FlowCytIntra-species-dilution-info": "1/1 - 1/5", "FlowCytIntra-species-notes": "<p><a href='/en-us/products/primary-antibodies/mouse-igg2c-kappa-monoclonal-18c8bc7ad10-isotype-control-ab170191'>ab170191</a> - Mouse monoclonal IgG2a, is suitable for use as an isotype control with this antibody.</p>", "IHCP-species-checked": "testedAndGuaranteed", "IHCP-species-dilution-info": "5-10 µg/mL", "IHCP-species-notes": "<p></p> Perform enzymatic antigen retrieval before commencing with IHC staining protocol." } } }

Product details

What is this antibody validated in?
Anti-Cytokeratin 19 antibody [A53-B/A2] - Cytoskeleton Marker (ab7754) is a mouse monoclonal antibody and is validated for use in Western Blot (WB), Flow Cytometry (Intra), Flow Cytometry (Flow Cyt), Immunohistochemistry (IHC-P), Immunocytochemistry/immunofluorescence (ICC/IF) in Human samples.

What is the molecular weight of Cytokeratin 19?
Anti-Cytokeratin 19 [A53-B/A2] - Cytoskeleton Marker (ab7754) specifically detects a band for Cytokeratin 19 (UniProt: P08727) at a molecular weight of 44kDa.

Trusted by the scientific community
Anti-Cytokeratin 19 [A53-B/A2] - Cytoskeleton Marker (ab7754) was first used in a scientific publication in 2001 and has been cited over 50 times in peer-reviewed journals.

Reviewed by scientists
Anti-Cytokeratin 19 [A53-B/A2] - Cytoskeleton Marker (ab7754) has over 5 independent reviews from customers.

Specificity confirmed
The specificity of Anti-Cytokeratin 19 antibody [A53-B/A2] - Cytoskeleton Marker (ab7754) has been confirmed by Immunocytochemistry testing in Cytokeratin 19 Knockout MCF7 cells.

Other related products
We have a range of other formats of antibody clone [A53-B/A2] also available for your convenience: ab7754, FITC - ab178543

Properties and storage information

Form
Liquid
Purification technique
Affinity purification Protein A
Storage buffer
pH: 7.4 Preservative: 0.097% Sodium azide Constituents: PBS
Shipped at conditions
Blue Ice
Appropriate short-term storage conditions
+4°C
Appropriate long-term storage conditions
+4°C
Aliquoting information
Upon delivery aliquot
Storage information
Do Not Freeze

Supplementary information

This supplementary information is collated from multiple sources and compiled automatically.

Cytokeratin 19 (CK19) also known as cytokera­tine 19 keratin 19 (KRT19) or CK19 is a type of intermediate filament found in epithelial cells. It serves as an essential component of the cytoskeleton. CK19 weighs approximately 40 kDa and is broadly expressed in simple epithelial tissues including liver intestine and various glandular epithelial cells. As a cytokeratin marker it often appears in combination with others like cytokeratin 17 in certain tissue types helping to maintain the structural integrity of cells.
Biological function summary

CK19 plays a role in maintaining the cytoskeletal framework that provides mechanical support and helps control cell size and shape. It is not part of a large protein complex but works closely with other cytokeratins to ensure the stability and resilience of epithelial tissues. The A53-B/A22.26 positive staining is often used to confirm its presence in clinical histopathology.

Pathways

CK19 connects to cellular processes especially involving the keratinization and epithelial cell differentiation pathways. It interacts with other cytokeratins including BA16 and KR17 to facilitate these processes. This interaction aids in modulating the dynamics of cytoskeletal rearrangement during cell movement division and differentiation.

CK19 overexpression is linked with certain cancers notably hepatocellular carcinoma and breast cancer. It can serve as a prognostic marker in these diseases often in conjunction with other markers like CK17. The involvement of CK19 in the epithelial-mesenchymal transition (EMT) process connects it to the progression and aggressiveness of tumors facilitated by interactions with proteins involved in EMT pathways.

Product protocols

For this product, it's our understanding that no specific protocols are required. You can visit:

Target data

Involved in the organization of myofibers. Together with KRT8, helps to link the contractile apparatus to dystrophin at the costameres of striated muscle.
See full target information KRT19

Publications (66)

Recent publications for all applications. Explore the full list and refine your search

BMC cancer 25:1506 PubMed41044692

2025

Expression and prognostic value of MCM2 in type B thymomas.

Applications

Unspecified application

Species

Unspecified reactive species

Xin Du,Jian Cui,Xintao Yu,Dingfang Cao,Ying Zhang,Lei Yu,Shanqing Li

Stem cells (Dayton, Ohio) 43: PubMed40574692

2025

Single-cell analysis of heterogeneity and molecular changes in cultured corneal epithelial stem cells during serial passage.

Applications

Unspecified application

Species

Unspecified reactive species

Usanee Reinprayoon,Supaporn Khramchantuk,Natthida Kittimawikrom,Praewphan Ingrungruanglert,Sarinya Phodang,Thanakorn Jaemthaworn,Sira Sriswasdi,Nipan Israsena

BJC reports 3:35 PubMed40394379

2025

Single-cell analysis reveals tumour size as a key driver of immune cell profile alterations in primary breast tumours and corresponding lymph nodes.

Applications

Unspecified application

Species

Unspecified reactive species

Marit Otterlei Fjørtoft,Øystein Garred,Ole Christian Lingjærde,Karin Teien Lande,Lars Ottestad,Inger Riise Bergheim,Jon Lømo,Colin LaMont,June Helen Myklebust,Hege Russnes,Kanutte Huse,Inga Hansine Rye

Nature communications 15:8690 PubMed39375367

2024

Single-cell RNA sequencing reveals the pro-inflammatory roles of liver-resident Th1-like cells in primary biliary cholangitis.

Applications

Unspecified application

Species

Unspecified reactive species

Ciliang Jin,Penglei Jiang,Zhaoru Zhang,Yingli Han,Xue Wen,Lin Zheng,Wei Kuang,Jiangshan Lian,Guodong Yu,Xinyue Qian,Yue Ren,Miaomiao Lu,Lingling Xu,Weixin Chen,Jiyang Chen,Yuwei Zhou,Jinxia Xin,Ben Wang,Xi Jin,Pengxu Qian,Yida Yang

Regenerative therapy 26:203-212 PubMed38948130

2024

Modified human skin cell isolation protocol and its influence on keratinocyte and melanocyte culture.

Applications

Unspecified application

Species

Unspecified reactive species

Zhi Liu,Shunxin Jin,Dapeng Cheng,Hao Chen,Yuxiang Wang,Chao Ji,Zhenzhen Yan,Xiao Fang,Shichu Xiao,Xinling Bi

International journal of molecular sciences 25: PubMed38892168

2024

Identification of a Novel miR-195-5p/PNN Axis in Colorectal Cancer.

Applications

Unspecified application

Species

Unspecified reactive species

Emanuele Piccinno,Viviana Scalavino,Nicoletta Labarile,Lucia De Marinis,Raffaele Armentano,Gianluigi Giannelli,Grazia Serino

Breast cancer research : BCR 26:11 PubMed38229104

2024

Evidence of steady-state fibroblast subtypes in the normal human breast as cells-of-origin for perturbed-state fibroblasts in breast cancer.

Applications

Unspecified application

Species

Unspecified reactive species

Mikkel Morsing Bagger,Jonas Sjölund,Jiyoung Kim,Katharina Theresa Kohler,René Villadsen,Abbas Jafari,Moustapha Kassem,Kristian Pietras,Lone Rønnov-Jessen,Ole William Petersen

Scientific reports 13:12261 PubMed37507439

2023

Full thickness 3D in vitro conjunctiva model enables goblet cell differentiation.

Applications

Unspecified application

Species

Unspecified reactive species

Julian Schwebler,Christina Fey,Daniel Kampik,Christian Lotz

The American journal of pathology 193:1156-1169 PubMed37263345

2023

Development of Scaffold-Free Three-Dimensional Cholangiocyte Organoids to Study the Progression of Primary Sclerosing Cholangitis.

Applications

Unspecified application

Species

Unspecified reactive species

Wenjun Zhang,Konstantina Kyritsi,Abdulkadir Isidan,Yujin Park,Ping Li,Arthur A Cross-Najafi,Kevin Lopez,Lindsey Kennedy,Keisaku Sato,Shannon Glaser,Heather Francis,Gianfranco Alpini,Burcin Ekser

Nature communications 14:861 PubMed36792623

2023

Coadaptation fostered by the SLIT2-ROBO1 axis facilitates liver metastasis of pancreatic ductal adenocarcinoma.

Applications

Unspecified application

Species

Unspecified reactive species

Qing Li,Xiao-Xin Zhang,Li-Peng Hu,Bo Ni,Dong-Xue Li,Xu Wang,Shu-Heng Jiang,Hui Li,Min-Wei Yang,Yong-Sheng Jiang,Chun-Jie Xu,Xue-Li Zhang,Yan-Li Zhang,Pei-Qi Huang,Qin Yang,Yang Zhou,Jian-Ren Gu,Gary Gui-Shan Xiao,Yong-Wei Sun,Jun Li,Zhi-Gang Zhang
View all publications

Product promise

We are committed to supporting your work with high-quality reagents, and we're here for you every step of the way. In the unlikely event that one of our products does not perform as expected, you're protected by our Product Promise.
For full details, please see our Terms & Conditions

Please note: All products are 'FOR RESEARCH USE ONLY. NOT FOR USE IN DIAGNOSTIC OR THERAPEUTIC PROCEDURES'.

For licensing inquiries, please contact partnerships@abcam.com